DUBLIN and LAVAL, Quebec, March 25, 2014 /CNW/ - Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug ...
What is topical metronidazole used for? Topical metronidazole is applied to the skin to treat certain symptoms of rosacea. Rosacea is a long-term skin condition that can cause symptoms such as redness ...
Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% from ...
METROGEL (metronidazole) 1% gel pump by Galderma Galderma announced that MetroGel 1% (metronidazole) will now be supplied in a pump bottle. Galderma announced that MetroGel 1% (metronidazole) will now ...
CINCINNATI--(BUSINESS WIRE)--Prasco Laboratories, a Cincinnati-based pharmaceutical company, announced today it has entered into a distribution and supply agreement with Graceway Pharmaceuticals, LLC.
Background: Bacterial vaginosis (BV), a prevalent infection in women of reproductive age, is associated with increased risk of upper genital tract and sexually transmitted infections, and ...
Actavis, Inc. (NYSE: ACT), and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Actavis Specialty Brands (the "Company") has acquired worldwide rights to Valeant ...
The Directorate General of Foreign Trade (DGFT) has notified a new Standard Input Output Norm (SION) for metronidazole gel under the chemical & allied product category. This development comes as part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results